Emily Rice Published

FDA Approves New Reformulated COVID-19 Vaccine

A physician administers a shot into a woman's arm in a hospital setting.PhotoAlto/Michele Constantini

In an effort to stave off the worst of respiratory illness season, the Food and Drug Administration (FDA) on Monday approved a new COVID-19 vaccine for anyone six months or older.

The reformulated vaccine targets Omicron subvariants of the virus which are the most common types circulating and hospitalizing people.

If the Centers for Disease Control and Prevention (CDC) agree with the FDA in a decision on Tuesday, the new vaccine could be available by the end of the week.

The new vaccines are manufactured by Moderna and by Pfizer and its German partner, BioNTech.

Updated COVID-19 vaccines are expected to be free for most with private health insurance or coverage through Medicare or Medicaid. 

However, this is the first time the federal government will not be purchasing vaccines, so doctors, hospitals and pharmacies must order them directly.

Appalachia Health News is a project of West Virginia Public Broadcasting with support from Charleston Area Medical Center and Marshall Health.